阿斯利康?
And outline:
This talk will discuss the real world big data and advanced analytics that are uniquely presented in healthcare setting and pharma industry. Xia will speak about the strategic roadmap of applying big data analytics in full life cycle of medicines development spanning R&D and commercialization, then discuss several use cases of implementing big data analytics in AstraZeneca for insight generation and decision making. ?Xia will conclude her talk by presenting the new paradigm shift in treatment from one-size-fit-all medicines to precision medicines, and summarize three key challenges yet exciting opportunities in the era of big data and analytics in healthcare and pharma.
?
My bio:
Xia holds a director and senior leader position at Health Informatics team within advanced analytics center at AstraZeneca global medicines development unit. ?Xia has records of accomplishment in applying novel data driven solutions and real world data analytics to all phases of medicines development life cycles from early drug discovery to late phase clinical development and commercialization. Xia has 17 years of experience in pharmaceutical industry with scientific focus spanning neuroscience, infection, diabetes, respiratory and autoimmune therapeutic areas. Currently Xia is leading informatics efforts in AstraZeneca Real World Evidence (RWE) to support clinical and observational studies, medicines comparative effectiveness, payer & pricing strategy and marketing accessing research. Prior to stepping into the clinical domain, Xia was with the AstraZeneca drug discovery in the areas of informatics and computational modeling to support candidate drug identification and optimization. Xia holds a Ph.D. in computational chemistry and has extensive training in broad areas of Informatics.?